Formulation development of Carbamazepine-Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process

Journal of Supercritical Fluids

Volumn 55, Issue 3, 2011, Pages 1070-1078

  Shikhar, Abhijat ^a   Bommana, Murali Mohan ^a   Gupta, Simerdeep Singh ^a   Squillante, Emilio ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Co crystals; Dissolution rate; Inclusion complexes; Supercritical fluid process

Indexed keywords

ANTI-SOLVENTS; CARBAMAZEPINE; CO-CRYSTALS; CRYSTALLINITIES; DISSOLUTION RATE; DISSOLUTION RATES; EXOTHERMIC PEAKS; FORMULATION DEVELOPMENT; HOT-STAGE MICROSCOPY; INCLUSION COMPLEX; INCLUSION COMPLEXES; INTERMOLECULAR HYDROGEN BONDING; MELTING PEAK; NMR AND X-RAY; STARTING MATERIALS; SUPERCRITICAL FLUID PROCESS; X-RAY POWDER DIFFRACTION PATTERN;

AMIDES; COBALT; COBALT COMPOUNDS; CRYSTALS; DIFFERENTIAL SCANNING CALORIMETRY; DIFFRACTION; DISSOLUTION; EFFLUENT TREATMENT; HYDROGEN BONDS; MELTING; SCANNING ELECTRON MICROSCOPY; SUPERCRITICAL FLUIDS; X RAY POWDER DIFFRACTION;

CRYSTAL STRUCTURE;

EID: 78650231712     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2010.09.009     Document Type: Article

References (35)

1. G.L. Amidon, H. Lannernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 3 1995 413 420
2. K. Uekama, F. Hirayama, and T. Irie Cyclodextrin drug carrier systems Chemical Reviews 98 1998 2045 2076
3. E.M. Martin Del Valle Cyclodextrins and their uses: a review Process Biochemistry 39 2004 1033 1046
4. T. Loftsson, and D. Duchene Cyclodextrins and their pharmaceutical applications International Journal of Pharmaceutics 329 2007 1 11
5. T. Loftsson, and M.E. Brewster Cyclodextrins as pharmaceutical solubilizers Advanced Drug Delivery Reviews 59 2007 645 666
6. M.L. Peterson, M.B. Hickey, M.J. Zaworotko, and O. Almarsson Expanding the scope of crystal form evaluation in pharmaceutical science Journal of Pharmaceutical Sciences 9 3 2006 317 326
7. N. Blagden, M. de Matas, P.T. Gavan, and P. York Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Advanced Drug Delivery Reviews 59 2007 617 630
8. Y. He, P. Fu, X. Shen, and H. Gao Cyclodextrin-based aggregates and characterization by microscopy Micron 39 2007 495 516
9. L. Fernandez, M.C. Martinez-Oharriz, C. Martin, I. Velaz, M. Sanchez, and A. Zornoza Analysis of the complexation of Gemfibrozil with γ- and hydroxypropyl-γ-cyclodextrins Journal of Pharmaceutical and Biomedical Analysis 47 2008 943 948
10. R.L. Carrier, L.A. Miller, and I. Ahmed The utility of cyclodextrins for enhancing oral bioavailability Journal of Controlled Release 123 2007 78 99
11. S. Sethia, and E. Squillante Solid dispersion of CBZ in PVP K30 by conventional solvent evaporation and supercritical methods International Journal of Pharmaceutics 272 2004 1 10
12. N. Zerrouk, C. Chemtob, P. Arnaud, S. Toscani, and J. Dugue In vitro and in vivo evaluation of Carbamazepine-PEG 6000 solid dispersions International Journal of Pharmaceutics 225 1992 49 62
13. S. Choudhury, and K.F. Nelson Improvement of oral bioavailability of CBZ by inclusion in 2-hydroxypropyl-β-cyclodextrins International Journal of Pharmaceutics 85 1992 175 180
14. J.S. Smitha, R.J. MacRaea, and M.J. Snowden Effect of SBE7-β-cyclodextrin complexation on CBZ release from sustained release beads European Journal of Pharmaceutics and Biopharmaceutics 60 2005 73 80
15. R.G. Kelmann, G. Kuminek, H.F. Teixeira, and L.S. Koester CBZ parenteral nanoemulsions prepared by spontaneous emulsification process International Journal of Pharmaceutics 342 2007 231 239
16. L.S. Koester, C.R. Xavier, R. Mayorga, and V.L. Bassani Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropylmethylcellulose matrix tablets European Journal of Pharmaceutics and Biopharmaceutics 55 2003 85 91
17. 2 on crystalline to amorphous conversion of carbamazepine International Journal of Pharmaceutics 333 2007 152 161
18. D.J. Berry, C.C. Seaton, W. Clegg, R.W. Harrington, S.J. Coles, P.N. Horton, M.B. Hursthouse, R. Storey, W. Jones, T. Friscic, and N. Blagden Applying hot-stage microscopy to co-crystal screening: a study of NCT with seven active pharmaceutical ingredients Crystal Growth and Design 8 5 2008 1697 1712
19. N. Shan, and M.J. Zaworotko The role of cocrystals in pharmaceutical science Drug Discovery Today 13 9/10 2008 440 446
20. G.A. Koutsou, D.M. Storey, and A. Bär Gastrointestinal tolerance of γ-cyclodextrin in humans Food Additives and Contaminants 16 1999 313 317
21. I.C. Munro, P.M. Newberne, R.R. Young, and A. Bär Safety assessment of γ-cyclodextrin Regulatory Toxicology and Pharmacology 39 1 2004 3 13
22. P. Jansook, and T. Loftsson γCD/HPγCD: synergistic solubilization International Journal of Pharmaceutics 363 2008 217 219
23. T. Yasuji, H. Takeuchi, and Y. Kawashima Particle design of poorly water-soluble drug substances using supercritical fluid technologies Advanced Drug Delivery Reviews 60 2008 388 398
24. S. Sethia, and S. Squillante Solid dispersions: revival with greater possibilities and applications in oral drug delivery Critical Reviews in Therapeutic Drug Carrier Systems 20 2&3 2003 215 247
25. I. Pasquali, R. Bettini, and F. Giordano Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals Advanced Drug Delivery Reviews 60 2008 399 410
26. R. Bettini, L. Bonassi, V. Castoro, A. Rossi, L. Zema, A. Gazzaniga, and F. Giordano Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide European Jounal of Pharmaceutical Sciences 13 3 2001 281 286
27. S.J. Nehm, B. Rodrguez-Spong, and N. Rodrguez-Hornedo Phase solubility diagram of co-crystals are explained by solubility product and solution complexation Crystal Growth and Design 6 2 2006 592 600
28. M. Perrut Supercritical fluid technology: a new route for particle design and nano-structured materials Bulletin of the Israel Chemical Society 23 2008 18 20
29. K. Seefeldt, J. Miller, F. Alvarez-Nunez, and N. Rodriguez-Hornedo Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy and calorimetry studies Journal of Pharmaceutical Sciences 96 2007 1147 1158
30. S.G. Fleischman, S.S. Kuduva, J.A. McMahon, B. Moulton, R.D. Bailey Walsh, N. Rodriguez-Hornedo, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine Crystal Growth and Design 3 6 2003 909 919
31. S.H. Yalkowsky, and S.C. Valvani Solubility and partitioning I: solubility of nonelectrolytes in water Journal of Pharmaceutical Sciences 69 1980 912 922
32. R.R. Schartman On the thermodynamics of cocrystal formation International Journal of Pharmaceutics 365 2009 77 80
33. G. Becket, L.J. Schep, and M.Y. Tan Improvement of the in vitro dissolution of praziquantel by complexation with α-β- and γ-cyclodextrins International Journal of Pharmaceutics 179 1999 65 71
34. 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid Journal of Pharmaceutical and Biomedical Analysis 23 2000 25 31
35. H.S. Whang, F.A.P. Vendeix, H.S. Gracz, J. Gadsby, and A. Tonelli NMR studies of the inclusion complex of cloprostenol sodium salt with α-cyclodextrin in aqueous solution Pharmaceutical Research 5 2008 1142 1149